To sweat or not to sweat? A hypothesis on the effects of venlafaxine and SSRIs

Medical Hypotheses

Volumn 74, Issue 1, 2010, Pages 155-157

  Demling, Joachim ^a   Beyer, Sabine ^a   Kornhuber, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BENZATROPINE; CITALOPRAM; CLONIDINE; CYPROHEPTADINE; DESVENLAFAXINE; FLUOXETINE; NORADRENALIN; PAROXETINE; PROPRANOLOL; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TERAZOSIN; VENLAFAXINE;

ADRENERGIC SYSTEM; ARTICLE; BRAIN REGION; DRUG ANTAGONISM; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RECEPTOR BINDING; HOT FLUSH; HUMAN; HYPOTHESIS; LOW DRUG DOSE; MENOPAUSAL SYNDROME; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SEROTONINERGIC NERVE CELL; SIDE EFFECT; SIGNAL TRANSDUCTION; SWEAT GLAND DISEASE; SWEATING; THERMOREGULATION; VASODILATATION;

CYCLOHEXANOLS; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NOREPINEPHRINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SWEAT; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 70450248464     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.07.011     Document Type: Article

References (21)

1. Garber A., and Gregory R.J. Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry 58 4 (1997) 176-177
2. Loprinzi C., Kugler J.W., Sloan J.A., Maillard J.A., LaVasseur B.I., Barton D.L., et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356 (2000) 2059-2063
3. Shanafelt T.D., Barton D.L., Adjei A.A., and Loprinzi C.L. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 77 (2002) 1207-1218
4. Stearns V., Ulmer L., López J.F., Smith Y., Isaacs C., and Hayes D.F. Hot flushes. Lancet 360 (2002) 1851-1861
5. Pierre J., and Guze B. Benztropine for venlafaxine-induced night sweats. J Clin Psychopharmacol 20 2 (2000) 269
6. Leeman C.P. Pathophysiology of tricyclic-induced sweating. J Clin Psychiatry 51 (1990) 258-259
7. Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry 56 (1995) 35
8. Mago R., and Monti D. Antiadrenergic treatment of antidepressant-induced excessive sweating in 3 patients. J Clin Psychiatry 68 4 (2007) 639-640
9. Butt M.M. Managing antidepressant-induced sweating. J Clin Psychiatry 50 4 (1989) 146-147
10. Ashton A.K., and Weinstein W.L. Cyproheptadine for drug-induced sweating. Am J Psychiatry 159 5 (2002) 874-875
11. Speroff L., Gass M., Constantine G., and Olivier S. Study 315 Investigators. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial. Obstet Gynecol 111 1 (2008) 77-87
12. Medgett I.C., Fearn H.J., and Rand M.J. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors. Clin Exp Pharmacol Physiol 11 (1984) 343-346
13. Ramage A.G., and Villalon C.M. 5-hydroxytrptamine and cardiovascular regulation. Trends Pharmacol Sci 29 9 (2008) 472-481
14. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13 (2003) 1357-1366
15. Benarroch E.E. Thermoregulation. Recent concepts and remaining questions. Neurology 69 (2007) 1293-1297
16. Salmi P., and Ahlenius S. Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms. Pharmacol Toxicol 82 (1998) 122-127
17. Stahl S.M. Basic psychopharmacology of antidepressants, part 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59 Suppl. 4 (1998) 5-14
18. Musselman DL, DeBattista C, Nathan KI, Kilts CD, Schatzberg AF, Nemeroff CB. Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology. 3rd ed. Washington, London: American Press; 1998. p. 549-88.
19. Schwartz T.L. Diaphoresis and pruritus with extended-release venlafaxine. Ann Pharmacother 33 9 (1999) 1009
20. Grady-Weliky T.A., and Hartmann D.M. Flushing in a menopausal woman taking venlafaxine. Am J Psychiatr 158 (2001) 1330
21. Linden M., Ludewig K., Munz T., and Dierkes W. Dosage finding and outcome of venlafaxine treatment in psychiatric outpatients and inpatients: results of a drug utilization observation study. Pharmacopsychiat 46 (2003) 197-205